Compass Therapeutics (CMPX) EPS (Basic) (2018 - 2026)
Compass Therapeutics (CMPX) posted EPS (Basic) of -$0.29 for Q1 2026, down 148.94% sequentially from -$0.11 in Q4 2025, and down 137.25% YoY from $0.77 in Q1 2025.
Powered by 
Analysis
Compass Therapeutics (CMPX) EPS (Basic) (2018 - 2026) Analysis & Trends
Compass Therapeutics has reported EPS (Basic) for 9 years, with the latest figure at -$0.29 in Q1 2026.
- Quarterly EPS (Basic) fell 137.25% year-over-year to -$0.29 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.68 (down 56.65% YoY) and the FY2025 annual result came in at -$0.96, down 14.18% from the prior year.
- EPS (Basic) retreated to -$0.29 in Q1 2026 per CMPX's latest filing, from -$0.11 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.06 in Q1 2023 and troughed at -$0.29 in Q1 2026.
- A 5-year average of -$0.12 and a median of -$0.11 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2026: EPS (Basic) soared 50.91% in 2022, then sank 137.25% in 2026.
- Over 5 years, EPS (Basic) stood at -$0.11 in 2022, then rose by 4.19% to -$0.11 in 2023, then slipped by 16.14% to -$0.12 in 2024, then gained by 6.5% to -$0.11 in 2025, then sank by 148.94% to -$0.29 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.29, -$0.11, and -$0.16 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.76 Bn | 131.91 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.72 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.56 Bn | 58.38 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.87 Bn | 52.73 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.06 Bn | 44.06 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.08 Bn | 34.98 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.20 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.54 Bn | 27.70 Bn | - | 0.18 |
| 9 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | -0.06 |
| 10 | Compass Therapeutics | 448.32 Mn | 448.32 Mn | - | -0.14 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.14 |
| Mar 31, 2026 | -0.11 |
| Dec 31, 2025 | -0.11 |
| Sep 30, 2025 | -0.09 |
| Jun 30, 2025 | -0.15 |
| Mar 31, 2025 | -0.12 |
| Dec 31, 2024 | -0.12 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | -0.10 |
| Mar 31, 2024 | -0.08 |
| Dec 31, 2023 | -0.11 |
| Sep 30, 2023 | -0.08 |
| Jun 30, 2023 | -0.09 |
| Mar 31, 2023 | -0.06 |
| Dec 31, 2022 | -0.11 |
| Sep 30, 2022 | -0.12 |
| Jun 30, 2022 | -0.08 |
| Mar 31, 2022 | -0.07 |
| Dec 31, 2021 | -0.21 |
| Sep 30, 2021 | -0.10 |